Cavalier King Charles Spaniels (CKCS) are among the most affectionate, gentle companion breeds, but they carry one of the highest lifetime veterinary cost profiles in purebred canine medicine. Unlike breeds whose medical expenses stem from accidental trauma or orthopedic cruciate tears, Cavaliers face near-universal hereditary conditions—chiefly myxomatous mitral valve disease (MMVD) and Chiari-like malformation with syringomyelia (CM/SM)—that require years of advanced imaging, specialized cardiology consultations, expensive daily prescription drugs, and intensive hospitalization.

For a Cavalier owner, buying pet insurance is not a casual price-comparison exercise. It is a time-critical race against the first clinical note in the veterinary record. If you enroll after a veterinarian writes "soft heart murmur" or "scratches at neck" in a puppy chart, that single line can permanently eliminate coverage for tens of thousands of dollars in lifetime cardiac and neurological care.

                      ┌──────────────────────────────────────────┐
                      │    Cavalier King Charles Spaniel Care    │
                      └────────────────────┬─────────────────────┘
                                           │
                 ┌─────────────────────────┴─────────────────────────┐
                 ▼                                                   ▼
   ┌───────────────────────────┐                       ┌───────────────────────────┐
   │    ENROLLMENT AT 8 WEEKS  │                       │   DELAYED ENROLLMENT      │
   │  (Clean Medical Record)   │                       │ (First Murmur Documented) │
   ├───────────────────────────┤                       ├───────────────────────────┤
   │ • No pre-existing history │                       │ • "Soft systolic murmur"  │
   │ • Complete waiting periods│                       │ • All future MMVD, echo,  │
   │ • Eligible B2 echo,       │                       │   pimobendan, and CHF     │
   │   pimobendan, and MRI     │                       │   hospitalization DENIED  │
   │   claims can still be paid│                       │                           │
   └───────────────────────────┘                       └───────────────────────────┘

How Much Does Cavalier Pet Insurance Cost, and Why Is It Above Average?

Modeled Cavalier accident-and-illness quotes sit above all-breed dog averages, but the markup is not a single percentage. MoneyGeek's July 2026 Cavalier model averaged about $104 per month across ages and coverage selections (101st most expensive breed in that ranking). NAPHIA's published US dog accident-and-illness average, summarized on our cost page, is $62.44 per month. Those are different methodologies, not a VetMedGuide invoice.

Modeled 2026 rate benchmarks from two public sources—Lemonade's published age table (updated 3 June 2026) and MoneyGeek's Cavalier model (updated 20 July 2026)—show a steep age curve. Figures below are labeled quotes or models, not guaranteed premiums:

                      ┌──────────────────────────────────────────┐
                      │    PUBLISHED / MODELED MONTHLY RATES     │
                      └────────────────────┬─────────────────────┘
                                           │
         ┌───────────────────┬─────────────┴───────┬───────────────────┐
         ▼                   ▼                     ▼                   ▼
┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐
│ LEMONADE AGE 1  │ │ LEMONADE AGE 7  │ │ MONEYGEEK MODEL │ │ MONEYGEEK AVG   │
├─────────────────┤ ├─────────────────┤ ├─────────────────┤ ├─────────────────┤
│  $40 – $45 / mo │ │  $75 – $80 / mo │ │ From $23 / mo   │ │ ~$104 / mo      │
│ Published table │ │ Published table │ │ cheapest quote  │ │ all ages/forms  │
│ June 2026       │ │ June 2026       │ │ (AR Lemonade)   │ │ July 2026 model │
└─────────────────┘ └─────────────────┘ └─────────────────┘ └─────────────────┘

Pricing Disclaimer: These are modeled or carrier-published benchmarks as of summer 2026, not guaranteed quotes. Actual premiums vary by state, zip code, reimbursement rate, deductible, and annual resets. VetMedGuide does not sell insurance or receive carrier placement fees.

Why Is the Breed So Expensive? The Epidemiological Evidence

To understand why insurers underwrite Cavaliers so strictly, owners must look at peer-reviewed veterinary epidemiology rather than marketing brochures.

                    ┌─────────────────────────────────────────┐
                    │      CAVALIER EPIDEMIOLOGICAL REALITY   │
                    └────────────────────┬────────────────────┘
                                         │
             ┌───────────────────────────┴───────────────────────────┐
             ▼                                                       ▼
  ┌─────────────────────────────────────┐ ┌─────────────────────────────────────┐
  │     PRIMARY CARE EPIDEMIOLOGY       │ │       AGED ECHOCARDIOGRAPHY         │
  │      (Summers et al. 2015)          │ │        (Russo et al. 2021)          │
  ├─────────────────────────────────────┤ ├─────────────────────────────────────┤
  │ • 1,749 primary-care CKCS records   │ │ • 126 CKCS older than 8 years       │
  │ • Heart murmur in 30.9% (541 dogs)  │ │ • 100% (126/126) had MMVD on echo   │
  │ • Cardiac disorders affected 31.7%  │ │ • 55.6% had chamber enlargement     │
  │ • #1 most common specific disorder  │ │ • 44.4% MMVD without remodeling     │
  └─────────────────────────────────────┘ └─────────────────────────────────────┘

1. Primary Care Prevalence (VetCompass): In a comprehensive epidemiological study of 1,749 Cavalier King Charles Spaniels attending primary care veterinary practices in England by Summers et al. (Canine Genetics and Epidemiology, 2015; DOI: 10.1186/s40575-015-0016-7), heart murmur was the single most frequently recorded specific disorder, affecting 30.9% (541 of 1,749 dogs), with cardiac disorders collectively diagnosed in 31.7% of the population.
2. Aged Echocardiographic Series: In a prospective echocardiographic investigation of 126 Cavalier King Charles Spaniels aged 8 years and older by Russo et al. (Animals, 2021; 11(4):949), echocardiographic evidence of MMVD was identified in 100% (126/126) of the dogs. Among these aged Cavaliers, 55.6% exhibited cardiac remodeling (left atrial and ventricular chamber enlargement), while 44.4% maintained stable MMVD without enlargement.
3. The Clinical Implication: Mitral valve disease is not a rare bad-luck event in Cavaliers; it is an age-dependent structural certainty. Insurers know that nearly every Cavalier will require cardiac evaluation during their lifespan.

Will a Policy Cover Mitral Valve Disease, Pimobendan, and CHF Hospitalization?

Yes—provided the policy includes hereditary conditions and the dog was enrolled before any murmur or cardiac sign was observed or documented.

Reimbursement follows the official staging standard established by the ACVIM Consensus Guidelines for the Diagnosis and Treatment of Myxomatous Mitral Valve Disease in Dogs (Keene et al., Journal of Veterinary Internal Medicine, 2019; PMID: 30974015):

                   ┌──────────────────────────────────────────────┐
                   │         ACVIM MMVD CLINICAL STAGING          │
                   └──────────────────────┬───────────────────────┘
                                          │
     ┌──────────────────┬─────────────────┴────────────────┬──────────────────┐
     ▼                  ▼                                  ▼                  ▼
┌───────────┐     ┌───────────┐                      ┌───────────┐      ┌───────────┐
│  STAGE A  │     │ STAGE B1  │                      │ STAGE B2  │      │  STAGE C  │
├───────────┤     ├───────────┤                      ├───────────┤      ├───────────┤
│ At-risk   │     │ Murmur    │                      │ Murmur +  │      │ Active or │
│ breed; no │     │ present;  │                      │ cardiomeg;│      │ past CHF; │
│ murmur or │     │ normal    │                      │ pimobendan│      │ pulmonary │
│ structural│     │ heart size│                      │ delays CHF│      │ edema; ICU│
│ change yet│     │ on echo   │                      │ by ~15 mo │      │ care      │
└───────────┘     └───────────┘                      └───────────┘      └───────────┘

• Stage A (At-Risk Breed): All purebred Cavaliers are Stage A from birth. No treatment is indicated.
• Stage B1 (Asymptomatic Murmur, Normal Heart Size): A systolic click or murmur is audible on auscultation, but echocardiography and thoracic radiographs reveal no cardiac chamber enlargement. No medication is indicated; annual or semi-annual echo monitoring is standard. Learn more in our heart murmur in dogs guide.
• Stage B2 (Asymptomatic Cardiomegaly): The murmur has progressed and echocardiography confirms significant left atrial and left ventricular remodeling meeting the landmark EPIC Trial criteria (Boswood et al., JVIM, 2016; PMID: 27678080: LA/Ao ratio ≥ 1.6, normalized left ventricular internal diastolic diameter ≥ 1.7, vertebral heart score > 10.5).
  • ACVIM Guideline Recommendation: Initiation of the inodilator pimobendan (Vetmedin). In the EPIC trial, pimobendan extended the median time to congestive heart failure or cardiac death from 766 days (placebo) to 1,228 days—a disease delay of approximately 15 months (HR 0.64).
  • Insurance Coverage: Policies covering prescription drugs reimburse daily pimobendan ($90–$160/month, totaling $1,100–$2,000 annually for life; review product safety in our Vetmedin guide).
• Stage C (Congestive Heart Failure): The dog develops acute pulmonary edema, coughing, tachypnea, and respiratory distress.
  • Clinical Consensus Protocol: Intensive emergency ICU hospitalization, oxygen therapy, high-dose intravenous furosemide diuresis, pimobendan, spironolactone, and ACE inhibitors (enalapril/benazepril). Read clinical details in our review of congestive heart failure in dogs.
  • Insurance Coverage: An ICU admission for acute CHF is often billed in the $2,500 to $6,000 range per episode. On a typical 80–90% reimbursement form, most of that can be paid after the deductible if hereditary cardiac disease is covered and nothing cardiac is pre-existing.

What Happens If a Veterinarian Writes "Soft Murmur" on a Puppy Exam?

The single most devastating claim denial in Cavalier ownership occurs when a caregiver delays insurance enrollment until after a puppy's initial veterinary checkup.

  Caregiver Brings 9-Week-Old Puppy to Vet
                    │
                    ▼
  Vet Auscultates Grade 1/6 Soft Systolic Murmur
                    │
                    ▼
  Vet Charts: "Quiet Grade 1/6 murmur; likely physiological flow murmur; re-check."
                    │
                    ▼
  Owner Purchases Pet Insurance 2 Weeks Later
                    │
                    ▼
  Age 5: Dog Develops Stage B2 MMVD & Needs Cardiologist Echocardiogram ($850)
                    │
                    ▼
  Insurer Audits Full Medical Records Back to Puppyhood
                    │
                    ▼
  CLAIM DENIED: Pre-Existing Condition Exclusion Applies to ALL Future Heart Care

The Legal Mechanics of the "Puppy Murmur" Denial:

1. Symptoms, Not Diagnosis, Trigger Pre-Existing Clauses: Pet insurance policies do not require a definitive specialist diagnosis (like "MMVD") to classify a condition as pre-existing. The presence of any clinical sign, symptom, or charted physical examination abnormality prior to enrollment or during the 14-day illness waiting period establishes the exclusion (review policy mechanics in our hub on pet insurance pre-existing conditions).
2. Innocent vs. Pathological Ambiguity: In puppies under 16 weeks of age, quiet Grade 1–2/6 systolic murmurs are frequently benign "flow murmurs" that resolve as hematocrit rises. Claims adjusters often do not distinguish a resolved flow murmur from early mitral disease. Once "murmur" is in the record before the policy is in force, later MMVD care is at high risk of being treated as pre-existing. That is a contract-interpretation trap, not a guarantee that every carrier will deny every cardiac invoice.
3. Waiting Period Traps: Even if enrolled at 8 weeks, if the puppy visits the vet for a booster vaccine on Day 10 of a 14-day illness waiting period and a murmur is auscultated, the condition is deemed pre-existing (see state laws and rules in our guide on pet insurance waiting periods).

Does Pet Insurance Cover Chiari-Like Malformation, Syringomyelia, and MRI?

Chiari-like malformation (CM) is a structural mismatch where the caudal occipital bone of the skull is too small to accommodate the cerebellum, herniating cerebellar tissue into the foramen magnum and obstructing normal cerebrospinal fluid (CSF) flow. This pressure differential causes fluid-filled cavities (syrinxes) to develop within the cervical spinal cord—a condition known as syringomyelia (SM).

                      ┌──────────────────────────────────────────┐
                      │    CM / SM CLINICAL & DIAGNOSTIC PATH    │
                      └────────────────────┬─────────────────────┘
                                           │
         ┌───────────────────┬─────────────┴───────┬───────────────────┐
         ▼                   ▼                     ▼                   ▼
┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐
│ CLINICAL SIGNS  │ │  ADVANCED MRI   │ │ MEDICAL THERAPY │ │ SURGICAL OPTION │
├─────────────────┤ ├─────────────────┤ ├─────────────────┤ ├─────────────────┤
│ Phantom scratch,│ │ Brain & cervical│ │ Neuropathic pain│ │ Cranial occipital│
│ head/neck pain, │ │ spine MRI under │ │ drugs: gabapen, │ │ decompression   │
│ scoliosis,      │ │ general GA      │ │ pregabalin,     │ │ ($6,000–$12,000;│
│ touch aversion  │ │ ($2,500–$4,500) │ │ omeprazole, pred│ high recurrence)  │
└─────────────────┘ └─────────────────┘ └─────────────────┘ └─────────────────┘

• Clinical Signs: "Phantom scratching" (scratching at the air near the neck or shoulder without making skin contact, especially when walking on a leash), crying out when picked up under the chest, severe neck tenderness, head rubbing, and facial pain.
• Diagnostic Requirements: Definitive confirmation requires a high-field magnetic resonance imaging (MRI) scan of the brain and cranial cervical spinal cord performed under general anesthesia by a board-certified veterinary neurologist ($2,500–$4,500).
• Insurance Coverage Traps:
  • Hereditary / Congenital Exclusions: Budget or accident-only policies explicitly exclude developmental skull malformations.
  • Extended Neurological Waiting Periods: Certain carriers impose a 6-month waiting period on neurological or spinal disorders unless waived by a specialist orthopedic/neurological exam.
  • Phantom Scratching in Medical History: If an owner casually mentions to a vet, "He scratches at his collar a lot," that record notation can be weaponized to deny future MRI claims for syringomyelia.

Will Liavium-CA1 (Pregabalin) Be Covered After FDA Conditional Approval?

On May 12, 2026, the FDA Center for Veterinary Medicine (CVM) granted conditional approval to Liavium-CA1 (pregabalin chewable tablets) for the control of pain and clinical signs associated with Chiari-like malformation and syringomyelia in dogs.

                    ┌─────────────────────────────────────────┐
                    │      LIAVIUM-CA1 2026 COVERAGE WRINKLE   │
                    └────────────────────┬────────────────────┘
                                         │
             ┌───────────────────────────┴───────────────────────────┐
             ▼                                                       ▼
  ┌─────────────────────────────────────┐ ┌─────────────────────────────────────┐
  │     FDA CONDITIONAL APPROVAL        │ │     INSURANCE POLICY FINE PRINT     │
  ├─────────────────────────────────────┤ ├─────────────────────────────────────┤
  │ • Granted May 12, 2026              │ │ • Many policies exclude             │
  │ • Legally marketed for CM/SM pain   │ │   "investigational, experimental,   │
  │ • Proven safety & reasonable        │ │   or conditionally approved drugs"  │
  │   expectation of efficacy           │ │ • Requires auditing Rx clause       │
  └─────────────────────────────────────┘ └─────────────────────────────────────┘

• The Coverage Conflict: While Liavium-CA1 is an FDA-authorized labeled treatment for CM/SM pain (review labeled indications in our guide on Liavium-CA1 for Chiari-like malformation), standard US pet insurance policy forms often state that medications deemed "investigational, experimental, or conditionally approved under FDA expanded access" are excluded from formulary reimbursement until full approval is finalized.
• Actionable Advice for Owners: If your neurologist prescribes Liavium-CA1, submit a pre-authorization claim to your insurer. If the carrier denies the conditionally approved brand, ask your veterinarian whether compounded or generic human pregabalin (prescribed extra-label) meets your policy's standard prescription drug criteria.

Other Breed Conditions: Dry Eye, Patella, and Ear Disease

Beyond heart and neurological disease, Cavaliers are genetically predisposed to several other high-cost chronic disorders:

Accident-Only vs. Accident-and-Illness: The Wrong Product Trap

Pet insurance policies fall into two main structural categories:

1. Accident-Only: Covers physical injuries from unexpected external events (car accidents, torn nails, lacerations, foreign body ingestion, snake bites, bee stings).
2. Accident-and-Illness: Covers accidents plus medical diseases, infections, hereditary disorders, congenital defects, and chronic conditions.

                      ┌──────────────────────────────────────────┐
                      │    POLICY TYPE FIT FOR A CAVALIER SPANIEL│
                      └────────────────────┬─────────────────────┘
                                           │
                 ┌─────────────────────────┴─────────────────────────┐
                 ▼                                                   ▼
   ┌───────────────────────────┐                       ┌───────────────────────────┐
   │     ACCIDENT-ONLY         │                       │  ACCIDENT & ILLNESS       │
   ├───────────────────────────┤                       ├───────────────────────────┤
   │ ✗ Mitral Valve Disease    │                       │ ✓ Illness path if not     │
   │ ✗ Syringomyelia / MRI     │                       │   pre-existing and        │
   │ ✗ Pimobendan / Rx         │                       │   hereditary is included  │
   │ ✗ Dry Eye / Topicals      │                       │ ✓ Rx if the rider/form    │
   │ ✗ CHF ICU Diuresis        │                       │   actually covers drugs   │
   │ Wrong product for CKCS    │                       │ Matches this breed's risk │
   └───────────────────────────┘                       └───────────────────────────┘

The Decision Rule: An accident-only policy is the wrong product for a Cavalier. The conditions that make the breed expensive—MMVD, CM/SM, KCS—are illnesses, not accidents. Accident-only will not pay for echo, MRI, pimobendan, or CHF hospitalization. This is educational coverage logic, not insurance advice.

A Worked Claim Scenario: 6-Year-Old Cavalier with Stage B2 MMVD

To see how reimbursement math works, here is a labeled hypothetical Year 1 scenario for a 6-year-old Cavalier diagnosed with Stage B2 MMVD. Assumed terms: $250 annual deductible, 90% reimbursement, unlimited annual maximum, prescription drugs included. Actual invoices and policy math will differ.

The Clinical Scenario:

• Patient: "Oliver," a 6-year-old Cavalier King Charles Spaniel enrolled at 8 weeks with a clean medical history.
• Policy Terms: $250 annual deductible, 90% reimbursement rate, unlimited annual payout maximum, prescription drug rider included.
• Incident: During his annual exam, Oliver's primary veterinarian hears a new Grade 3/6 systolic heart murmur. Oliver is referred to a board-certified veterinary cardiologist.

                      ┌──────────────────────────────────────────┐
                      │      YEAR 1 MMVD INVOICE BREAKDOWN       │
                      └────────────────────┬─────────────────────┘
                                           │
         ┌───────────────────┬─────────────┴───────┬───────────────────┐
         ▼                   ▼                     ▼                   ▼
┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐ ┌─────────────────┐
│ CARDIOLOGY WORK │ │  LABORATORY LABS│ │ LIFELONG VETMEDIN│ │ 6-MONTH RECHECK │
├─────────────────┤ ├─────────────────┤ ├─────────────────┤ ├─────────────────┤
│ Echocardiogram, │ │ NT-proBNP card- │ │ Daily pimobendan│ │ Recheck echo &  │
│ ECG, and 3-view │ │ iac biomarker,  │ │ chewable tablets│ │ BP measurement  │
│ chest x-rays    │ │ renal chemistry │ │ (Year 1 supply) │ │ to monitor size │
│ Invoiced: $1,150│ │ Invoiced: $250  │ │ Invoiced: $1,440│ │ Invoiced: $650  │
└─────────────────┘ └─────────────────┘ └─────────────────┘ └─────────────────┘

The Claim Calculations:

• Total Invoiced Veterinary Expenses: $1,150 (Cardiology) + $250 (Labs) + $1,440 (Pimobendan) + $650 (Recheck Echo) = $3,490.00
• Covered Amount After Annual Deductible: $3,490.00 - $250.00 = $3,240.00
• Insurance Payout (90% Reimbursement): $3,240.00 × 0.90 = $2,916.00
• Total Caregiver Out-of-Pocket Cost: $250.00 (Annual Deductible) + $324.00 (10% Copay) = $574.00

Financial Outcome:

The caregiver's modeled Year 1 insurance reimbursement in this hypothetical is $2,916. Later years depend on whether the dog stays in Stage B2, whether pimobendan remains covered, and whether a CHF hospitalization occurs. Those later-year totals are not a promised payout.

5-Point Policy Checklist for Cavalier Owners

Before signing any pet insurance contract for a Cavalier, verify these five clauses:

                    ┌─────────────────────────────────────────┐
                    │      5-POINT CAVALIER POLICY AUDIT      │
                    └────────────────────┬────────────────────┘
                                         │
     ┌──────────────────┬────────────────┼────────────────┬──────────────────┐
     ▼                  ▼                ▼                ▼                  ▼
┌───────────┐     ┌───────────┐    ┌───────────┐    ┌───────────┐      ┌───────────┐
│ HEREDITARY│     │ ANNUAL CAP│    │ RX DRUGS  │    │ NEURO WAIT│      │ PRE-EXIST │
├───────────┤     ├───────────┤    ├───────────┤    ├───────────┤      ├───────────┤
│ Included  │     │ Unlimited │    │ Covers    │    │ 14–30 days│      │ Enrolled  │
│ by default│     │ or $10k+  │    │ chronic   │    │ max; no   │      │ before 1st│
│ without   │     │ (chronic  │    │ lifelong  │    │ 6-month   │      │ vet chart │
│ sub-limits│     │ MMVD/ICU) │    │ pimobendan│    │ MRI delay │      │ murmur note│
└───────────┘     └───────────┘    └───────────┘    └───────────┘      └───────────┘

1. Hereditary and Congenital Coverage Included by Default: Ensure MMVD, Chiari-like malformation, syringomyelia, and luxating patellas are not excluded or subject to lower sub-limits (e.g., "$1,000 lifetime cardiac limit").
2. High or Unlimited Annual Maximum: Avoid policies capped at $3,000 or $5,000 annually. A single CHF crisis or spinal surgery quickly exceeds $6,000.
3. Comprehensive Prescription Drug Coverage: Confirm that chronic, lifelong maintenance medications (Vetmedin, enalapril, gabapentin, cyclosporine eye drops) are reimbursed under standard illness benefits.
4. Short Neurological Waiting Periods: Choose carriers with standard 14-day illness waiting periods for neurological disorders rather than 6-month restrictions.
5. Clean Enrollment Before First Chart Note: Enroll the puppy at 8 weeks old before any veterinarian auscultates the heart or documents scratching behavior.

Frequently Asked Questions

How much does it cost to insure a Cavalier King Charles Spaniel?

In 2026, Lemonade's published Cavalier table listed about $40 to $45 per month at age 1 and $75 to $80 per month at age 7. MoneyGeek's July 2026 Cavalier model showed named-carrier quotes from the mid-$30s to about $51 for younger dogs, a breed-wide average near $104 per month, and location ranges of about $70 to $135 for a 6-year-old. Your quote will differ by zip code, deductible, and limit.

Should I wait to see if my Cavalier develops a heart murmur before buying insurance?

No. If you wait until a veterinarian documents a murmur, that finding can be used to classify later cardiac care as pre-existing. Many accident-and-illness forms will then deny echocardiograms, cardiologist consults, pimobendan, and CHF hospitalization tied to that murmur. Read the pre-existing clause rather than assuming a denial is automatic on every form.

Does pet insurance cover heart disease in Cavaliers?

Yes, as long as the policy covers hereditary conditions and the dog was enrolled before any murmur, heart disease symptom, or cardiac abnormality was noted in their medical records or during the policy waiting period.

Is $50 a month a lot for Cavalier pet insurance?

No. For a young Cavalier, $50 per month sits near Lemonade's published age-1 band ($40–$45) and inside MoneyGeek's named-carrier models. Whether that is "a lot" depends on deductible, limit, and zip code, not on a ranking site's "best" badge. Cardiac and neurologic care in this breed can run to several thousand dollars a year once Stage B2 or CM/SM is active.

Does pet insurance cover syringomyelia surgery or MRI scans?

They can be, under comprehensive accident-and-illness policies that include hereditary conditions, after waiting periods, and if no scratching, pain, or neurologic signs were documented before coverage began. Published 2026 specialist-fee ranges for brain/cervical MRI are often $2,500–$4,500 and for cranial decompression $6,000–$12,000; those are estimates, not invoices.

Sources

• Boswood, A., et al. (2016). Effect of Pimobendan in Dogs with Preclinical Myxomatous Mitral Valve Disease and Cardiomegaly: The EPIC Study. Journal of Veterinary Internal Medicine, 30(6), 1765–1779. PubMed PMID: 27678080.
• FDA Center for Veterinary Medicine. (2026). FDA Conditionally Approves Drug to Control Pain and Clinical Signs of Chiari-Like Malformation and Syringomyelia in Dogs. May 12, 2026 update.
• Keene, B. W., et al. (2019). ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs. Journal of Veterinary Internal Medicine, 33(3), 1127–1140. PubMed PMID: 30974015.
• Lemonade. (2026). Cavalier King Charles Spaniel Pet Insurance. Updated June 3, 2026.
• MoneyGeek. (2026). Cavalier King Charles Spaniel Insurance (2026 Guide). Updated July 20, 2026.
• Russo, M., et al. (2021). Clinical and Echocardiographic Findings in an Aged Population of Cavalier King Charles Spaniels. Animals, 11(4), 949. DOI: 10.3390/ani11040949.
• Summers, L. V., O'Neill, D. G., Church, D. B., Thomson, P. C., McGreevy, P. D., & Brodbelt, D. C. (2015). Prevalence of disorders recorded in Cavalier King Charles Spaniels attending primary-care veterinary practices in England. Canine Genetics and Epidemiology, 2, 4. DOI: 10.1186/s40575-015-0016-7.